Cellmid 2018 Annual Report
The effect of the arrangement is akin to an option. The value of the shares at the date of grant was $0.0183 per share.
400,000 shares are vested and held in escrow as of 30 June 2018. Vesting condition 2 was not met at 25 November 2016.
Loans to directors and other members of key management personnel
There were no loans to directors or other members of key management personnel during or since the end of the ﬁnancial year.
This concludes the remuneration report which has been audited.
Auditor’s independence declaration
The auditor’s independence declaration in accordance with section 307C of the Corporations Act 2001 for the year ended
30 June 2018 has been received and can be found on page 64 of the ﬁnancial report.
This director’s report, incorporating the remuneration report, is signed in accordance with a resolution of the Board of Directors.
Dated this 19th day of September 2018